189 related articles for article (PubMed ID: 34952753)
1. Effectiveness of TBE vaccination in southern Germany and Latvia.
Erber W; Khan F; Zavadska D; Freimane Z; Dobler G; Böhmer MM; Jodar L; Schmitt HJ
Vaccine; 2022 Jan; 40(5):819-825. PubMed ID: 34952753
[TBL] [Abstract][Full Text] [Related]
2. A systematic literature review of the effectiveness of tick-borne encephalitis vaccines in Europe.
Angulo FJ; Zhang P; Halsby K; Kelly P; Pilz A; Madhava H; Moïsi JC; Jodar L
Vaccine; 2023 Nov; 41(47):6914-6921. PubMed ID: 37858450
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of tick-borne encephalitis vaccination in Latvia, 2018-2020: an observational study.
Zavadska D; Freimane Z; Karelis G; Ermina I; Harper LR; Bender C; Zhang P; Angulo FJ; Erber W; Bormane A; Gutmane E; Litauniece ZA; Tihonovs J; Griskevica A; Madhava H; Jodar L
Clin Microbiol Infect; 2023 Nov; 29(11):1443-1448. PubMed ID: 37422077
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Tick-borne Encephalitis Vaccines in Children, Latvia, 2018-2020.
Zavadska D; Freimane Z; Karelis G; Ermina I; Harper LR; Bender C; Zhang P; Angulo FJ; Erber W; Bormane A; Griskevica A; Moïsi JC; Jodar L
Pediatr Infect Dis J; 2023 Oct; 42(10):927-931. PubMed ID: 37406220
[TBL] [Abstract][Full Text] [Related]
5. Can the booster interval for the tick-borne encephalitis (TBE) vaccine 'FSME-IMMUN' be prolonged? - A systematic review.
Steffen R; Erber W; Schmitt HJ
Ticks Tick Borne Dis; 2021 Sep; 12(5):101779. PubMed ID: 34298356
[TBL] [Abstract][Full Text] [Related]
6. Vaccination rate and adherence of tick-borne encephalitis vaccination in Germany.
Schley K; Malerczyk C; Beier D; Schiffner-Rohe J; von Eiff C; Häckl D; Süß J
Vaccine; 2021 Jan; 39(5):830-838. PubMed ID: 33414049
[TBL] [Abstract][Full Text] [Related]
7. Characterization of tick-borne encephalitis (TBE) foci in Germany and Latvia (1997-2000).
Süss J; Schrader C; Abel U; Bormane A; Duks A; Kalnina V
Int J Med Microbiol; 2002 Jun; 291 Suppl 33():34-42. PubMed ID: 12141755
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a 10-year TBE vaccine booster interval: an evaluation of current data.
Schelling J; Einmahl S; Torgler R; Larsen CS
Expert Rev Vaccines; 2024; 23(1):226-236. PubMed ID: 38288983
[TBL] [Abstract][Full Text] [Related]
9. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
Wittermann C; Izu A; Petri E; Gniel D; Fragapane E
Vaccine; 2015 Apr; 33(15):1824-9. PubMed ID: 25728316
[TBL] [Abstract][Full Text] [Related]
10. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
Wittermann C; Petri E; Zent O
Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
[TBL] [Abstract][Full Text] [Related]
11. Self-reported tick-borne encephalitis (TBE) vaccination coverage in Europe: Results from a cross-sectional study.
Erber W; Schmitt HJ
Ticks Tick Borne Dis; 2018 May; 9(4):768-777. PubMed ID: 29501619
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
[TBL] [Abstract][Full Text] [Related]
13. A combined cross-sectional analysis and case-control study evaluating tick-borne encephalitis vaccination coverage, disease and vaccine effectiveness in children and adolescents, Switzerland, 2005 to 2022.
Zens KD; Altpeter E; Wymann MN; Mack A; Baer NB; Haile SR; Steffen R; Fehr JS; Lang P
Euro Surveill; 2024 May; 29(18):. PubMed ID: 38699900
[TBL] [Abstract][Full Text] [Related]
14. Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults.
Konior R; Brzostek J; Poellabauer EM; Jiang Q; Harper L; Erber W
Vaccine; 2017 Jun; 35(28):3607-3613. PubMed ID: 28545923
[TBL] [Abstract][Full Text] [Related]
15. Tick-borne encephalitis (TBE) in Germany--epidemiological data, development of risk areas and virus prevalence in field-collected ticks and in ticks removed from humans.
Süss J; Schrader C; Falk U; Wohanka N
Int J Med Microbiol; 2004 Apr; 293 Suppl 37():69-79. PubMed ID: 15146987
[TBL] [Abstract][Full Text] [Related]
16. Implementation of preventive measures against tick-borne infections in a non-endemic area for tick-borne encephalitis-Results from a population-based survey in Lower Saxony, Germany.
Caputo M; Stumpe V; Rübsamen N; Mikolajczyk RT; Karch A
Ticks Tick Borne Dis; 2019 Apr; 10(3):614-620. PubMed ID: 30797728
[TBL] [Abstract][Full Text] [Related]
17. Irregular tick-borne encephalitis vaccination schedules: the effect of a single catch-up vaccination with FSME-IMMUN. A prospective non-interventional study.
Schosser R; Reichert A; Mansmann U; Unger B; Heininger U; Kaiser R
Vaccine; 2014 Apr; 32(20):2375-81. PubMed ID: 24613521
[TBL] [Abstract][Full Text] [Related]
18. Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trial.
Kantele A; Rombo L; Vene S; Kundi M; Lindquist L; Erra EO
Vaccine; 2022 Feb; 40(9):1299-1305. PubMed ID: 35101266
[TBL] [Abstract][Full Text] [Related]
19. [Tick-borne encephalitis--an update].
Stock I
Med Monatsschr Pharm; 2016 May; 39(5):190-6. PubMed ID: 27348895
[TBL] [Abstract][Full Text] [Related]
20. A cross-sectional study evaluating tick-borne encephalitis vaccine uptake and timeliness among adults in Switzerland.
Zens KD; Baroutsou V; Sinniger P; Lang P
PLoS One; 2021; 16(12):e0247216. PubMed ID: 34905534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
